ArticleThe Effect of Primary Tumor Site on Survival in Metastatic Colorectal Cancer Patients and their Relation to KRAS and Biological Therapy
ArticleThe Effect of Primary Tumor Site on Survival in Metastatic Colorectal Cancer Patients and their Relation to KRAS and Biological Therapy
ArticleAngiogenesis Versus Antiangiogenesis in Colorectal Cancer Patients with and Without Liver Metastases
ArticleAngiogenesis Versus Antiangiogenesis in Colorectal Cancer Patients with and Without Liver Metastases
ArticleAnti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer
ArticleAnti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer
ArticleFOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy
ArticleFOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy
ArticlePrognostic factors and outcome of surgical management and adjuvant chemotherapy of advanced stage colorectal cancer: a single institution experienc
ArticlePrognostic factors and outcome of surgical management and adjuvant chemotherapy of advanced stage colorectal cancer: a single institution experienc
ArticleThe Prognostic Significance of the Metastatic Lymph Node Ratio versus the Number of Affected Lymph Nodes in Patients with Colorectal Cancer Stage III Undergoing Potentially Curati
ArticleThe Prognostic Significance of the Metastatic Lymph Node Ratio versus the Number of Affected Lymph Nodes in Patients with Colorectal Cancer Stage III Undergoing Potentially Curati
ArticlePrognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line
ArticlePrognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line